• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风与外周动脉疾病患者主要不良心血管事件和全因死亡率的关系。

Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease.

机构信息

Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.

The Department of Vascular and Endovascular Surgery, The Townsville Hospital, Townsville, Queensland, Australia.

出版信息

Atherosclerosis. 2020 Nov;312:23-27. doi: 10.1016/j.atherosclerosis.2020.08.029. Epub 2020 Sep 8.

DOI:10.1016/j.atherosclerosis.2020.08.029
PMID:32947223
Abstract

BACKGROUND AND AIMS

Prior epidemiological studies have suggested that individuals with gout are at greater risk of cardiovascular events, but there have been no studies in people with peripheral artery disease (PAD). The aim of this study was to investigate the relationship between gout and major adverse cardiovascular events (MACE) and all-cause mortality in people with PAD.

METHODS

Participants with a range of PAD presentations, including carotid artery disease, aortic or peripheral aneurysm and lower limb PAD, were prospectively recruited from outpatient vascular departments within Australia. MACE (myocardial infarction, stroke or cardiovascular death) and all-cause mortality were identified through out-patient follow-up and linked medical records. Propensity-score matching was undertaken to generate a matched cohort of patients with and without a history of gout. Kaplan-Meier survival analysis and Cox-proportional hazard analysis were used to examine the association of gout with MACE and all-cause mortality.

RESULTS

A total of 4308 people with PAD, of whom 334 had a history of gout, were included and followed for a median (inter-quartile range) of 2.1 (0.1-5.9) years. In the unadjusted analyses, participants with gout were at increased risk of MACE (hazard ratio, HR 1.37, 95% confidence intervals, CI 1.09-1.71, p = 0.006) and all-cause mortality (HR 1.38, 95% 1.13-1.68, p = 0.002), however, the associations were lost in the adjusted analyses. In the propensity-score matched cohort, gout was not significantly associated with an increased risk for MACE or all-cause mortality.

CONCLUSIONS

Gout was not independently associated with increased cardiovascular events in PAD patients.

摘要

背景与目的

先前的流行病学研究表明,痛风患者发生心血管事件的风险更高,但针对外周动脉疾病(PAD)患者尚无相关研究。本研究旨在探讨痛风与 PAD 患者的主要不良心血管事件(MACE)和全因死亡率之间的关系。

方法

本前瞻性研究从澳大利亚门诊血管科招募了多种 PAD 表现(包括颈动脉疾病、主动脉或外周动脉瘤以及下肢 PAD)的患者。通过门诊随访和查阅病历记录确定 MACE(心肌梗死、卒中和心血管死亡)和全因死亡率。采用倾向评分匹配生成了一组痛风史患者和无痛风史患者的匹配队列。使用 Kaplan-Meier 生存分析和 Cox 比例风险分析来评估痛风与 MACE 和全因死亡率之间的关联。

结果

共纳入 4308 例 PAD 患者,其中 334 例有痛风史,中位(四分位距)随访时间为 2.1(0.1-5.9)年。在未校正分析中,痛风患者发生 MACE 的风险增加(风险比 1.37,95%置信区间 1.09-1.71,p=0.006)和全因死亡率(风险比 1.38,95%置信区间 1.13-1.68,p=0.002),但在校正分析中,相关性消失。在倾向评分匹配的队列中,痛风与 MACE 或全因死亡率的增加无关。

结论

痛风与 PAD 患者的心血管事件增加无关。

相似文献

1
Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease.痛风与外周动脉疾病患者主要不良心血管事件和全因死亡率的关系。
Atherosclerosis. 2020 Nov;312:23-27. doi: 10.1016/j.atherosclerosis.2020.08.029. Epub 2020 Sep 8.
2
Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.队列研究考察了免疫抑制剂药物处方与外周动脉疾病患者主要不良心血管和肢体事件的关联。
Ann Vasc Surg. 2022 Jan;78:310-320. doi: 10.1016/j.avsg.2021.07.010. Epub 2021 Sep 16.
3
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.血清脂蛋白 (a) 与外周动脉疾病患者外周动脉手术需求及主要不良心血管事件发生率的关系。
J Am Heart Assoc. 2020 Mar 17;9(6):e015355. doi: 10.1161/JAHA.119.015355. Epub 2020 Mar 14.
4
Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes.外周动脉疾病合并糖尿病患者中可改变危险因素的控制与主要不良心血管事件
World J Diabetes. 2021 Jun 15;12(6):883-892. doi: 10.4239/wjd.v12.i6.883.
5
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.替格瑞洛用于外周动脉疾病患者心肌梗死后预防缺血事件。
J Am Coll Cardiol. 2016 Jun 14;67(23):2719-2728. doi: 10.1016/j.jacc.2016.03.524. Epub 2016 Apr 1.
6
Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.脑血管病和/或外周动脉疾病患者降脂目标达标与未达标对冠状动脉疾病患者长期预后的影响。
Am J Cardiol. 2020 Aug 1;128:28-34. doi: 10.1016/j.amjcard.2020.04.043. Epub 2020 May 13.
7
Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.慢性血管疾病患者的饮食摄入与心血管结局:来自 COMPASS 试验队列的观察。
Eur J Prev Cardiol. 2023 Jun 1;30(8):709-718. doi: 10.1093/eurjpc/zwad062.
8
The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.外周动脉疾病对心肌梗死后主要不良心血管事件的影响。
Int J Cardiol. 2021 Nov 15;343:131-137. doi: 10.1016/j.ijcard.2021.08.053. Epub 2021 Sep 6.
9
High ankle brachial index predicts high risk of cardiovascular events amongst people with peripheral artery disease.高踝肱指数预测外周动脉疾病患者心血管事件发生的高风险。
PLoS One. 2020 Nov 12;15(11):e0242228. doi: 10.1371/journal.pone.0242228. eCollection 2020.
10
Cohort study examining the relationship between remoteness and requirement for surgery to treat peripheral artery disease at a tertiary hospital in North Queensland.在北昆士兰州的一家三级医院进行的队列研究,考察了偏远程度与外周动脉疾病手术治疗需求之间的关系。
Aust J Rural Health. 2021 Aug;29(4):512-520. doi: 10.1111/ajr.12776. Epub 2021 Aug 4.

引用本文的文献

1
Impact of gout on cardiovascular disease mortality: a meta-analysis.痛风对心血管疾病死亡率的影响:一项荟萃分析。
Z Rheumatol. 2024 Dec;83(Suppl 3):329-337. doi: 10.1007/s00393-024-01479-x. Epub 2024 Feb 1.